Current location - Trademark Inquiry Complete Network - Trademark inquiry - What about Teyi Pharmaceutical Group Co., Ltd.?
What about Teyi Pharmaceutical Group Co., Ltd.?

Introduction: Guangdong Taicheng Pharmaceutical Co., Ltd. is located in Taishan City, Jiangmen, a famous hometown of overseas Chinese in the Pearl River Delta of Guangdong Province. It currently has a registered capital of 75 million yuan, covers an area of ??100,000 square meters, and has 30,000 square meters. modern factory building. At the same time, the company adheres to the corporate purpose of "focusing on quality, strengthening research and development, and sustainable development" and adheres to the business strategy of "relying on mature brands, taking advantageous varieties as the core, and targeting corporate benefits", and is mainly engaged in Chinese patent medicines and chemical preparations. R&D, production and sales. The company is a high-tech enterprise. Currently, the production workshops of all dosage forms have passed the pharmaceutical GMP certification. It has been rated as "Private Technology Enterprise in Guangdong Province", "Top 20 Enterprises in the Pharmaceutical Industry of Guangdong Province for Traditional Chinese Medicine Piece Processing and Chinese Patent Medicine Manufacturing in 2008", "The fourth batch of innovative pilot enterprises in Guangdong Province" and "Enterprises that abide by contracts and value credit". The company's "Ningcheng" and "Teyi" trademarks have been recognized as "Guangdong Province Famous Trademarks" by the Guangdong Provincial Administration for Industry and Commerce. At the same time, the company has strong technology development capabilities. The technology center has been recognized as a provincial technology center. While adhering to independent research and development as the leading role, it has cooperated with units such as Guangdong Pharmaceutical College, Guangdong Food and Drug Vocational College and Shandong Medical Device Research Institute. Through close cooperation, 10 national quality standards for drugs and medicinal materials have been independently and jointly formulated. The company currently has production approval documents for 11 dosage forms and 181 drug varieties, and daily produces and sells 68 varieties and 69 specifications of various dosage forms of drugs, mainly involving cough-reducing and phlegm-reducing drugs, kidney-tonifying drugs and anti-infective drugs. The main products include Zhike Bao Tablets , Jingui Shenqi Tablets, Erythromycin Enteric-coated Tablets, Erythromycin Tablets, Nystatin Tablets and Akafol Powder and other high-quality varieties. Among the main products currently produced by the company, Zhikebao Tablets, Jingui Shenqi Tablets, Etoerythromycin Tablets and Nystatin Tablets all rank first in sales nationwide, and Erythromycin Enteric-coated Tablets rank first in the market. Second, Akafol powder ranks third in the market. At the same time, the company's Zhike Bao Tablets ranked 18th in the national cough-relieving and phlegm-reducing market based on terminal sales volume, and ranked fourth among the cough-relieving and phlegm-reducing drugs in Guangdong Province. In addition, the secret recipe of Zhikebao Tablets was selected into the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in April 2009, including 14 Zhikebao Tablets, Jingui Shenqi Tablets, Erythromycin Enteric-coated Tablets, and Erythromycin Erythromycin Tablets. Two drugs were recognized as "Guangdong Province High-tech Products" by the Guangdong Provincial Science and Technology Department. In the future, the company will continue to increase its efforts in product research and development, production and sales, improve the construction of ERP information system, increase product structure adjustment, improve market competitiveness, and enhance the overall strength of the enterprise, with scientific management as the guarantee and quality and safety as its responsibility. , committed to building excellent brands and promoting the development of the national pharmaceutical industry.

Legal representative: Xu Danqing

Date of establishment: 2002-05-23

Registered capital: RMB 200 million

Affiliation Region: Guangdong Province

Unified social credit code: 91440700738598678Q

Business status: Operating (opening) enterprise

Industry: Manufacturing

< p>Company type: joint stock limited company (listed, natural person investment or holding)

English name: Guangdong Taicheng Pharmaceutical Co., Ltd.

Staff size: 500-999 people

p>

Business address: No. 9, 11, Changxing Road, Taicheng, Taishan City

Business scope: pharmaceutical manufacturing (operated with a valid "Drug Production License"); health product production; medical equipment, Wholesale of daily necessities; technical services; house rental. (Projects that require approval according to law can only be carried out with approval from relevant departments)〓